Pricing Log in Create free account

Codexis, Inc. (CDXS) vs Minerva Neurosciences, Inc (NERV)

Codexis, Inc. and Minerva Neurosciences, Inc are both Biotechnology companies. Codexis, Inc. and Minerva Neurosciences, Inc are of similar size ($111.7M and $109.8M). Minerva Neurosciences, Inc has the higher net margin (0.00% vs −39.6%) and the higher return on invested capital (0.00% vs −151.2%). Across the 13 metrics below, Minerva Neurosciences, Inc leads on 7 and Codexis, Inc. on 6.

Valuation

Metric CDXS NERV Biotechnology median
P/E n/m n/m 10.60
P/S 1.25 n/m 9.40
P/B 2.96 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 0.98 n/m 9.02
Earnings yield (31.78%) (1,172.31%) (32.88%)
Free cash flow yield (12.49%) (23.31%) (23.13%)

Profitability

Metric CDXS NERV Biotechnology median
Gross margin 87.02% 0.00% 68.51%
Operating margin (35.61%) 0.00% 0.00%
Net margin (39.55%) 0.00% 0.00%
Free cash flow margin (15.66%) 0.00% 0.00%
Return on equity (69.36%) 322.05% (51.96%)
Return on assets (23.79%) (629.71%) (46.06%)
Return on invested capital (151.17%) 0.00% 0.00%

Growth

Metric CDXS NERV Biotechnology median
Revenue growth (TTM) 35.89% — 6.76%
EPS growth (last fiscal year) 43.82% (18,347.37%) 29.88%
Revenue growth, 5-year CAGR 0.38% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CDXS NERV Biotechnology median
Debt to equity 1.03 0.00 0.00
Current ratio 3.06 20.14 4.97
Net debt to EBITDA 1.11 5.46 1.01

Dividend

Metric CDXS NERV Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CDXS NERV Biotechnology median
Market cap 111.70m 109.82m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack